Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida’s KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida’s KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Oct 27 2025

Full Issue

Viewpoints: Annual Open Enrollment Is About Making More Money; New Meds Make Dementia Less Scary

Editorial writers examine these public health topics.

Los Angeles Times: Open Enrollment Is Healthcare's Most Expensive Lie 

To give the illusion of choice, we’ve built a multibillion-dollar theater production called 'open enrollment' that costs more to stage than many small countries spend on their entire healthcare systems. (Neal K. Shah, 10/27)

Stat: How Dementia Is Becoming A Disease People Can Live With 

Diagnosis is interesting. Treatment is exciting. I’ve fond memories from early in my career prescribing medications that within minutes relieved patients smothering from congestive heart failure, pulled them back from near death from septic shock, or slowed the progression of their diabetes or heart disease. (Jason Karlawish, 10/27)

Newsweek: Gutting Special Ed Shows How Little America Thinks Of Its Children

If Office of Special Education layoffs remain in place, the office’s ability to monitor the constitutional rights of disabled students will suffer severely. (K. Ward Cummings and Anne Tapp Jaksa, 10/24)

Stat: More Pharmacies Are Closing. I Worry About My Father

When my father needs insulin, he drives 25 miles round trip to the nearest Walgreens in a remote corner of California. That trip takes him about 50 minutes, nearly an hour every time he needs his medication, if he has a car available. It is the only pharmacy within that distance where he can get his medication, a flu shot, or basic health advice. (Guadalupe Hayes-Mota, 10/27)

The Boston Globe: Why Undermining Vaccines Endangers Americans’ Freedom

Right now, that foundation of freedom is under assault — and the threat isn’t a virus. It’s the deliberate campaign to dismantle confidence in vaccines, which has now reached the highest levels of government. (Former White House covid response coordinator Ashish K. Jha, 10/27)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF